Back
Hut 8 Corp. Vs. Madrigal Pharmaceuticals, Inc. Industry Stock Comparison
Buy
64
HUT
Hut 8 Corp.
Last Price:
$41.32
Seasonality Move:
61.85%
Buy
64
MDGL
Madrigal Pharmaceuticals, Inc.
Last Price:
$571.29
Seasonality Move:
13.5%
Buy
64
Hut 8 Corp. (HUT)
is a Buy
Is Hut 8 Corp. a Buy, Sell or Hold?
-
The current Hut 8 Corp. [HUT] share price is $46.75. The Score for HUT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
HUT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Madrigal Pharmaceuticals, Inc. (MDGL)
is a Buy
Is Madrigal Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $571.33. The Score for MDGL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HUT Stock Price Chart
What is Hut 8 Corp.'s stock price today?
-
The Hut 8 Corp. share price today is $46.75The current trend is moderately bearish and HUT is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals, Inc.'s stock price today?
-
The Madrigal Pharmaceuticals, Inc. share price today is $571.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing slight buying pressure.
HUT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.67 | Buy |
| Relative Strength Index (14 RSI): | 57.78 | Buy |
| Chaikin Money Flow: | 4392340 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 21.16 | Buy |
| Relative Strength Index (14 RSI): | 59.59 | Buy |
| Chaikin Money Flow: | -8282 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
HUT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.95 | Buy |
| 20-day SMA: | 40.44 | Buy |
| 50-day SMA: | 44.04 | Buy |
| 200-day SMA: | 25.44 | Buy |
| 8-day EMA: | 43.96 | Buy |
| 20-day EMA: | 42.65 | Buy |
| 50-day EMA: | 41.17 | Buy |
| 200-day EMA: | 30.04 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 570.36 | Buy |
| 20-day SMA: | 566.12 | Buy |
| 50-day SMA: | 494.18 | Buy |
| 200-day SMA: | 376.04 | Buy |
| 8-day EMA: | 567.91 | Buy |
| 20-day EMA: | 555.34 | Buy |
| 50-day EMA: | 509.4 | Buy |
| 200-day EMA: | 402.22 | Buy |
Hut 8 Corp. Earnings Growth & HUT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.68 per share, and a decrease next year of $0.41 per share.
Madrigal Pharmaceuticals, Inc. Earnings Growth & MDGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $13.27 per share, and an increase next year of $13.90 per share.
Hut 8 Corp. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||